ArticleActive
Response to Comments: Immune Globulin
A59283
Novitas Solutions, Inc. (J12)
Effective: December 22, 2022
Updated: December 31, 2025
Policy Summary
This document contains summaries of public comments and contractor responses for Proposed Local Coverage Determination DL35093 (Immune Globulin) posted August 11, 2022 and presented at the Open Meeting on August 26, 2022. It states that comments were reviewed and incorporated into the final LCD where applicable, but does not itself restate specific coverage criteria, limitations, or documentation requirements from the LCD text.